Myriad Genetics Inc. Q1 Profit Rises 54%

(RTTNews) - Myriad Genetics Inc. (MYGN) announced earnings for its first quarter that climbed compared to the same period last year.

The company said its bottom line advanced to $29.8 million, or $0.41 per share. This was up from $19.4 million, or $0.25 per share, in last year's first quarter.

Analysts had expected the company to earn $0.35 per share, according figures compiled by Thomson Reuters. Analysts' estimates typically exclude special items.

The company said revenue for the quarter rose 8.7% to $183.5 million. This was up from $168.8 million last year.

Myriad Genetics Inc. earnings at a glance:

-Earnings (Q1): $29.8 Mln. vs. $19.4 Mln. last year. -Earnings Growth (Y-o-Y): 53.6% -EPS (Q1): $0.41 vs. $0.25 last year. -EPS Growth (Y-o-Y): 64.0% -Analysts Estimate: $0.35 -Revenue (Q1): $183.5 Mln vs. $168.8 Mln last year. -Revenue Change (Y-o-Y): 8.7%

-Guidance: Next quarter EPS guidance: $0.40 - $0.42 Next quarter revenue guidance: $188 - $190 Mln Full year EPS guidance: $1.60 - $1.65 Full year revenue guidance: $750 - $770 Mln